二地降糖丸治疗2型糖尿病45例临床观察(1)
 |
| 第1页 |
参见附件。
[摘要] 目的 观察二地降糖丸治疗2型糖尿病的临床疗效并作安全性评价。 方法 将符合纳入标准的90例患者随机分为治疗组与对照组各45例；对照组口服格列喹酮、二甲双胍治疗，治疗组在对照组基础上加服二地降糖丸。 结果治疗组总有效率明显优于对照组(P < 0.05)，且治疗组在降低空腹血糖、餐后2 h血糖及糖化血红蛋白水平方面明显优于对照组(P < 0.05或P < 0.01)。 结论 二地降糖丸治疗2型糖尿病安全有效，无毒副作用。
[关键词] 2型糖尿病；中西医结合疗法；二地降糖丸
[中图分类号] R587.2 [文献标识码] B [文章编号] 1673—9701(2012)26—0077—02
Effect of Erdijiangtangwan in treatment of type 2 diabetes： A clinical observation of 45 cases
YANG Zhengyu PENG Yanhong
First Hospital of TCM of Yiyang in Hunan Province， Yiyang 413000， China
[Abstract] Objective To observe clinical efficacy in treating type—2 diabetes with Erdijiangtangwan and conduct the safety assessment. Methods A total of 90 cases meeting choice criteria were randomly divided into the treatment group of 45 cases and the control group of 45 cases. The control group was subject to the oral administration of gliquidone and metformin， and the treatment group was subject to gliquidone， metformin and Erdijiangtangwan. Results The treatment group was significantly better than the control group in the total efficiency (P < 0.05)； more， the treatment group was significantly better than the control group in reduction of fasting blood glucose， 2—hour postprandial blood glucose and glycosylated hemoglobin levels (P < 0.05 or P < 0.01). Conclusion Erdijiangtangwan is safe， effective and non—toxic in treatment of type 2 diabetes.
[Key words] Type 2 diabetes； Integrative therapy； Erdijiangtangwan
笔者于2009年5月～2011年5月对45例2型糖尿病患者采用二地降糖丸加常规西药治疗(下称治疗组)，并与单用常规西药治疗(下称对照组)进行临床疗效比较，现报道如下。
1 资料与方法
1.1 一般资料
治疗组45例中，男 25例，女 20例；年龄38～69岁，平均 (55.3±17.2)岁；病程2～6年，平均(4.2±2.1)年；对照组45例中 ......
您现在查看是摘要介绍页，详见PDF附件(3201kb)。